EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D

Ruilope L, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, Schmieder R, Joseph A, Mentenich N, Nowack C, Bakris G (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Nephrology Dialysis Transplantation Oxford University Press (OUP): Policy B

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: NEPHROLOGY DIALYSIS TRANSPLANTATION

DOI: 10.1093/ndt/gfab149.002

Authors with CRIS profile

Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

Research Institute Hospital 12 de Octubre (Imas12)

Spain (ES) Indiana University

United States (USA) (US) Charité - Universitätsmedizin Berlin

Germany (DE) National and Kapodistrian University of Athens

Greece (GR) University of Michigan

United States (USA) (US) Steno Diabetes Center

Denmark (DK) Aristotle University of Thessaloniki

Greece (GR) Bayer AG

Germany (DE) University of Chicago Medical Center

United States (USA) (US)

How to cite

APA:

Ruilope, L., Agarwal, R., Anker, S.D., Filippatos, G., Pitt, B., Rossing, P.,... Bakris, G. (2021). EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D. In NEPHROLOGY DIALYSIS TRANSPLANTATION. OXFORD: OXFORD UNIV PRESS.

MLA:

Ruilope, Luis, et al. "EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D." Proceedings of the NEPHROLOGY DIALYSIS TRANSPLANTATION OXFORD: OXFORD UNIV PRESS, 2021.

BibTeX: Download